Trial Profile
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Rheumatoid Arthritis With Persistently Active Disease Despite Dual-DMARD Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 06 Jun 2020 Results assessing the efficacy of repository corticotropin injection in persistently active rheumatoid-arthritis patients using clinical and patient-reported outcome measures (PROMs), were presented at the 21st Annual Congress of the European League Against Rheumatism.
- 15 Apr 2020 According to a Mallinckrodt media release, data from this study has been presented at the in Rheumatology and Therapy, an open access peer-review journal.
- 15 Apr 2020 Results published in the Mallinckrodt plc Media Release